Navigation Links
AspenBio Pharma to Present the Edgewater Research Investor Conference
Date:10/4/2007

Presentation to Include the Recently Released Strong Results from the Latest Pre-FDA Multi-Hospital Study using the AppyScore Human Appendicitis

Blood- based Screen / Triage Test

CASTLE ROCK, Colo., Oct. 4 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (Nasdaq: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, has been invited to present at the Edgewater Research Investor Conference, scheduled for October 10-11, 2007 at The Ventana Canyon Resort in Tucson, Arizona.

AspenBio Pharma president and CEO, Richard Donnelly, is scheduled to present on Wednesday, October 10, at 8:15 AM MST.

The presentation will include a discussion on the recently announced strong results from the latest pre-FDA multiple-hospital study using its AppyScore human appendicitis screen and triage blood test. The sensitivity of the screen test was 98% in the large study. The study also demonstrated that a significant percentage of CT scans could potentially be avoided leading to important patient health, medical utility and cost benefits. The study showed 58% of unnecessary surgeries could have been avoided, which also further exemplifies how this new appendicitis screen testing concept can provide exciting new capabilities and benefits for emergency medicine. The high level of sensitivity also means the test could reduce the risk of sending patients home because of a false negative diagnosis.

About EdgeWater Research Partners, LLC.

EdgeWater Research Partners is an independent micro cap equities research company representing the research of David Lavigne. EdgeWater follows a number of undiscovered small and micro ca
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...tria, November 19 AFFiRiS AG will ...ct candidate at an unexpectedly early,stage of dev... enter into,Phase II clinical trial early in 2010....the completion of two Phase I trials with the cand...ecision on the first interim,analysis of the secon...
(Date:11/18/2009)...to be able to find explosive materials and persons...earches, the National Institute of Standards and T... of Homeland Security, has developed a new certifi... (SRM) 2905, Trace Particulate Explosives. Compati...RM will be helpful in calibrating, testing and dev...
(Date:11/18/2009)...Nov. 18 Sangamo BioScien...ta from the University of Pennsylvania investigato... finger nuclease (ZFN) based product, SB-728-T, fo...losed on the internet. ,, Data were presented i...ia School of Medicine from a single subject treate...
(Date:11/18/2009)...t Sussex, U.K. and CLEVELAND, Nov. 18 /PRNewswire/...s business and premier provider of diagnostic syst...abs, has expanded its East Grinstead, U.K., manufa...eet increasing global demand for its Sensititre...tion testing. The expanded facility has been fully...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
...nce Inc. (NYSE:,CVD) today announced that it will ...ence on Tuesday, May 13, 2008 at 10:30 am ET. Inve...n at http://www.covance.com . In order to,registe...on 10 minutes,early., Covance, with headquarters ...rgest and most comprehensive drug development serv...
... USGI Medical, Inc. (USGI),the leader in incisionl...licensed its incisionless surgery technology to In... robotics applications. Financial terms of the dea...SGI,s technical and clinical development,including...president and,chief operating officer of Intuitive...
...Pharmaceuticals,Inc. (OTC Bulletin Board: NURX pre...ay 9th, the Company,s 1-for-4 reverse stock split ... the Over The Counter Bulletin,Board,s Corporate A...stock,split, its trading symbol has changed from N... the number of issued and,outstanding shares of Nu...
Other Biology Technology:USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical 2USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical 3NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect 2
(Date:11/19/2009)...TON, La. A team of researchers at Louisiana Tech ...croorganism acts as a natural herbicide against gi...invasive aquatic weed that can block all sunlight ...ecosystems. Under ideal conditions, it,s been rep... three days. , Dr. H. Lynn Walker, professor of ...
(Date:11/19/2009)...LAFAYETTE, Ind. - Purdue University scientists hav...e responsible for cell wall development in maize, ...ays to produce the biomass best suited for biofuel...cholas Carpita, a professor of plant cell biology,...es in the journal Plant Physiology on Thursday (...
(Date:11/19/2009)...LLA, CA November 19, 2009 A team led by scientist...d a direct link between insulina hormone long asso...h as diabetesand core body temperature. While much...discovery in the 1920s, this is the first time the...cess of temperature regulation. , The paper was ...
Breaking Biology News(10 mins):Microorganism may provide key to combating giant salvinia throughout Louisiana 2Maize cell wall genes identified, giving boost to biofuel research 2Scripps research scientists find new link between insulin and core body temperature 2Scripps research scientists find new link between insulin and core body temperature 3Scripps research scientists find new link between insulin and core body temperature 4Women Speak Out Against Government Takeover of Health Care 54776 1Women Speak Out Against Government Takeover of Health Care 54776 2Women Speak Out Against Government Takeover of Health Care 54776 3Brooks Opens New Center for Back 26 Neck Health 54774 1Brooks Opens New Center for Back 26 Neck Health 54774 2Brooks Opens New Center for Back 26 Neck Health 54774 3MicroDynamics to Introduce New Microscope at Quality Expo 54772 1
...s M. D. Anderson Cancer Center say they have jumpe...nce (RNAi), believed by many to be the ultimate to... in the human genome and to treat disease. , Repo...igators have developed a simple way to use the RNA...c tissue in a mouse to determine the function of t...
...sity of Illinois atUrbana-Champaign has a home in ...f the swine genome to be completed with the help o...tment of Agriculture announced today (Jan. 13) by ...Schook, a professor of animal sciences at Illinois... Sequencing Consortium, will head the project that...
...esistant to antibiotics, causing problems for ther...at work in new kinds of ways. The last few years o... major difficulty for developers of antibiotics is...ria. There are hundreds of possible points of atta...lture experiments ?but validation in in vivo infec...
Other Biology News:Tool developed to silence genes in specific tissues using RNAi 2Tool developed to silence genes in specific tissues using RNAi 3Illinois pig to make history as source of first complete swine genome 2Salmonella caught red-handed 2
Rabbit Anti-Human Atrophin 1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Bunyavirus (G1) Monoclonal Antibody, Unconjugated, Clone 8C2.1 from CHEMICON
Rabbit Anti-Complexin-1/2 (FL-134) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Human TP-1 Monoclonal Antibody, Unconjugated, Clone NDOG1 from Santa Cruz Biotechnology, Inc.
Biology Products: